UBLITUXIMAB vs UBROGEPANT: Which Drug Is Safer?
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
UBLITUXIMAB vs UBROGEPANT: Safety Overview
| Metric | UBLITUXIMAB | UBROGEPANT |
|---|---|---|
| Total FAERS Reports | 1,582 | 2,531 |
| Deaths Reported | 27 | 49 |
| Death Rate | 1.7% | 1.9% |
| Hospitalizations | 213 | 145 |
| Average Patient Age | 49.7 yrs | 49.2 yrs |
| % Female Patients | 73.4% | 83.6% |
| FDA Approval Date | N/A | Dec 23, 2019 |
| Manufacturer | TG Therapeutics, Inc. | Allergan, Inc. |
| Route | INTRAVENOUS | ORAL |
| Marketing Status | N/A | Prescription |